Chemotherapy Drugs Current Events | Chemotherapy Drugs News | 6
|
| Page
6 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
NC State Researchers Find Soy May Aid in Treating Canine Cancers
Researchers at North Carolina State University are looking to soy as a way to make traditional canine cancer therapy more effective, less stressful for the dog and less costly for the owners. view more (2009-04-09)
More older women with early stage breast cancer choose chemotherapy, GUMC researchers say
A new study examining treatment decision-making by older women with early stage breast cancer shows that 45 percent of women would choose to get chemotherapy after surgery -- a figure higher than the national average of women getting the additional treatment. view more (2009-05-15)
Cholesterol levels and use of lipid-lowering drugs are not associated with breast cancer risk
Cholesterol levels and use of statins or other lipid-lowering drugs are not associated with breast cancer risk, according to a study in the October 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. view more (2005-10-25)
UAB Study Shows Drug May Fight Biliary Cancers
Laboratory studies by University of Alabama at Birmingham (UAB) researchers have shown that the drug triphendiol (NV-196) causes cell death in pancreatic and bile duct cancer cell lines, slows tumor growth and sensitizes tumors to chemotherapy treatments. view more (2008-04-16)
Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women
A study in the Sept.1 issue of the journal Sleep shows that the sleep-wake activity rhythms of breast cancer patients are impaired during the administration of chemotherapy. view more (2009-09-01)
Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists. view more (2007-09-27)
Trial Supports Use of Marker to Predict How Pancreatic Cancer Patients Do After Surgery, Jefferson Surgeon Finds
A team of researchers, led by surgeons at the Kimmel Cancer Center at Jefferson in Philadelphia, has found further evidence supporting the ability of a protein to predict how well a patient with advanced pancreatic cancer will do after surgery, chemotherapy and radiation. view more (2007-06-25)
Study aims to find which breast cancer patients need chemotherapy
Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy. view more (2007-03-13)
First antisense drug provides benefit to subset of chronic lymphocytic leukemia patients
The first "antisense" drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients-those who are still sensitive to a chemotherapy drug often used to treat this cancer. view more (2007-02-15)
EphA2-targeted therapy delivers chemo directly to ovarian cancer cells
With a novel therapeutic delivery system, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center has successfully targeted a protein that is over-expressed in ovarian cancer cells. view more (2009-07-30)
Study supports DNA repair-blocker research in cancer therapy
Scientists at Dana-Farber Cancer Institute have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells' DNA with potent drugs while simultaneously preventing the cells from repairing themselves. view more (2009-08-18)
Tailored dosage of chemotherapy effective in treating breast cancer
By tailoring the dosage of chemotherapy to each individual patient, the treatment of breast cancer could be improved considerably. This is shown in a dissertation by Uppsala researcher Henrik Lindman at Uppsala University in Sweden. The method has proven to yield excellent results in clinical tests. The dissertation reports that an alternative way... view more... (2003-12-16)
Chemotherapy resistance: Checkpoint protein provides armor against cancer drugs
Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. view more (2009-08-28)
Targeting treatment
The effectiveness of many potentially powerful treatments including drug therapy, gene therapy and cancer chemotherapy is often reduced because it can be difficult to target the treatment exactly where it will be most effective. One of the problems is that it is frequently difficult for drugs, as well as DNA and other biological molecules, to pass... view more... (2002-03-26)
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease. view more (2009-06-25)
Finding of a new molecular marker of resistance to chemotherapy in breast cancer
A collaborative study between the IDIBAPS—Hospital Clínic of Barcelona and the Hospital del Mar de Barcelona permits to establish a predictive factor in the resistance to chemotherapy in breast cancer and to establish possible therapeutic targets for the improvement of this treatment. view more (2006-06-29)
Surgery not necessary for most late-stage colorectal cancers
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. view more (2009-06-01)
UC Davis researchers shed new light on how chemotherapy-induced leukemia develops
Topoisomerase II inhibitors are among the most successful chemotherapy drugs used to treat human cancer. view more (2005-11-16)
Novel and Effective Treatment for Soft Tissue Sarcoma in Children
Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys. The most common age for onset is between 1-5 years of age. The treatments... view more... (2004-07-15)
Complete response with oblimersen combination improves survival of CLL patients
Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American... view more... (2007-12-10)
|
|
| Page
6 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
|
